A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...

The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.

More than just a creator of labels – the company also offers customised packaging solutions that help brands stand out, connect with consumers and foster trust. From special effects and product ...

Acuity Brands (AYI) corporate name is changing from Acuity Brands to Acuity, effective March 26, 2025. Acuity will continue to operate through two business segments, Acuity Brands Lighting and ...

March 11, 2025 /PRNewswire/ -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced its eighth annual Female Founders list ...

Inc.'s eighth annual Female Founders list highlights the nation's top business leaders who challenge the status quo to tackle some of the world's biggest problems Each year, Inc. editors review ...

It does not necessarily reflect the view of The Herald. People are mourning the loss of big-name brands in Newport city centre after several closures. At a recent council meeting, Councillor ...

As these self-proclaimed successors to KFC continue to multiply, it has become an amusing inside joke among locals — and a reflection of our knack for taking "inspiration" from household brand names ...

In a report released today, Ryan Sigdahl from Craig-Hallum maintained a Hold rating on Solo Brands Inc Class A (DTC – Research Report). The company’s shares closed last Friday at $0.71.

Under the terms of the agreement, Biocon Biologics will supply Insulin Aspart drug substance to Civica, Inc., who will use the drug substance to produce Insulin Aspart drug product, a rapid-acting ...

Under the terms of the agreement, Biocon Biologics will supply insulin aspart drug substance to Civica, who will use the drug substance to produce insulin aspart drug product, a rapid-acting insulin ...

The company's subsidiary, Biocon Biologics, announced a strategic collaboration agreement with Civica, Inc. to expand access and affordability of Insulin Aspart in the United States. As per the ...